Nifedipine Retard Teva (Nifedipine)

Nifedipine blocks L‑type calcium channels in the smooth muscle of arteries and in cardiac muscle. This inhibition prevents calcium entry, leading to vasodilation, reduced peripheral resistance, and lower myocardial oxygen demand, which together control blood pressure and alleviate angina.

The specific dose and dosing schedule are determined by the prescribing clinician based on the patient’s condition, response, and other medical factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety in pregnancy and lactation has not been definitively established. The drug should only be used if the potential benefit justifies the possible risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nifedipine belongs to the calcium channel blocker class, which primarily causes arterial vasodilation. Compared with ACE inhibitors or beta‑blockers, it may have a quicker onset of blood‑pressure reduction but can be associated with peripheral edema. Choice of therapy depends on individual patient profile and comorbidities.

Store the tablets at room temperature, below 25 °C, in the original packaging. Protect them from moisture and direct sunlight to maintain stability. Do not refrigerate or freeze the product.

The medication is taken orally, usually with a full glass of water. It may be prescribed as a once‑daily or twice‑daily regimen, depending on the formulation and the prescriber’s recommendation. Swallow the tablet whole; do not crush or chew unless instructed otherwise.

Serious risks include severe hypotension, myocardial infarction, and life‑threatening allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience sudden dizziness, fainting, chest pain, or signs of an allergic response.

Individuals with known hypersensitivity to nifedipine or any component of the formulation should avoid the drug. Caution is also advised for patients with severe aortic stenosis, uncontrolled heart failure, or those taking contraindicated medications such as strong CYP3A4 inhibitors.